BioPharma Credit (LON:BPCP) Hits New 52-Week High – Should You Buy?

BioPharma Credit PLC (LON:BPCPGet Free Report)’s share price reached a new 52-week high during mid-day trading on Friday . The company traded as high as GBX 74.20 and last traded at GBX 74.20, with a volume of 126391 shares trading hands. The stock had previously closed at GBX 73.

BioPharma Credit Trading Up 1.6%

The firm’s fifty day moving average is GBX 71.93 and its 200 day moving average is GBX 70.44. The company has a market cap of £1.02 billion, a PE ratio of 10.96 and a beta of 0.18.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Featured Articles

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.